IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC September 21, 2022 by Alejandro
IGC Reports Financial Results for the Quarter Ended June 30, 2022 August 8, 2022August 8, 2022 by Alejandro
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022 June 23, 2022June 23, 2022 by Alejandro
IGC Acquires Exclusive Rights for a Potential Alzheimer’sDrug Development Candidate June 21, 2022June 21, 2022 by Alejandro
